Study of CB-839 in Combination w/ Paclitaxel in Participants of African Ancestry and Non-African Ancestry With Advanced Triple Negative Breast Cancer (TNBC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sam Whiting, MD, PhD
Calithera Biosciences, Inc
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Brimingham
Birmingham, Alabama, United States
- University of South Alabama, Mitchell Cancer Institute
Mobile, Alabama, United States
- Yale Cancer Center
New Haven, Connecticut, United States
- Georgetown University - Lombardi Comprehensive Cancer Center
Washington D.C., District of Columbia, United States
- Washington Cancer Institute
Washington D.C., District of Columbia, United States
- University of Miami
Miami, Florida, United States
- Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- University Cancer and Blood Center
Athens, Georgia, United States
- Winship Cancer Institute - Emory University
Atlanta, Georgia, United States
- Northwest Georgia Oncology
Marietta, Georgia, United States
- Ochsner Clinic Foundation
New Orleans, Louisiana, United States
- Weinberg Cancer Institute at Franklin Square
Baltimore, Maryland, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Saint Louis University
St Louis, Missouri, United States
- Jtcc at Hackensack Umc
Hackensack, New Jersey, United States
- Columbia University
New York, New York, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Magee Womens Hospital - Upmc
Pittsburgh, Pennsylvania, United States
- Charleston Hematology Oncology Associates
Charleston, South Carolina, United States
- Greenville Health System (ghs) Cancer Institute
Greenville, South Carolina, United States
- West Cancer Center
Germantown, Tennessee, United States
- Baylor College of Medicine
Houston, Texas, United States
- Md Anderson
Houston, Texas, United States
- Northwest Medical Specialties, Pllc
Tacoma, Washington, United States
- Froedtert and the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 May 2017
- Primary completion
- 25 Nov 2019
- Completion
- 25 Nov 2019
- Last update posted
- 28 Sept 2022
- Registered enrollment
- 52
- Registry id
- NCT03057600
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.